In this episode of the Peripheral Nerve Podcast, hosts Susanna Park and Paola Alberti are joined by Maryam Lustberg to explore the real-world impact of chemotherapy-induced peripheral neuropathy (CIPN). Together, they examine why CIPN remains such a persistent challenge in oncology care and discuss evolving approaches to assessment, management, and research. The conversation also looks ahead to emerging innovations and the growing importance of collaborative, patient-centered care.

Resources:

• Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship - https://pnsociety.com/wp-content/uploads/Ep.2-CIDP-Paper1-1May2026.pdf
• Evolution of predictive risk factor analysis for chemotherapy‑related toxicity - https://pnsociety.com/wp-content/uploads/Ep.2-CIDP-Podcast-Paper2-1May2026.pdf